Connection
Robert Dellavalle to Randomized Controlled Trials as Topic
This is a "connection" page, showing publications Robert Dellavalle has written about Randomized Controlled Trials as Topic.
|
|
Connection Strength |
|
|
|
|
|
0.747 |
|
|
|
-
Williams HC, Dellavalle RP. The growth of clinical trials and systematic reviews in informing dermatological patient care. J Invest Dermatol. 2012 Mar; 132(3 Pt 2):1008-17.
Score: 0.278
-
Pulsipher KJ, Presley CL, Waller JD, Szeto MD, Laughter MR, Dellavalle RP. Coronavirus Vaccination Adverse Reactions and the Role of the Dermatologist. J Drugs Dermatol. 2021 03 01; 20(3):351-352.
Score: 0.133
-
Schilling LM, Dellavalle RP. Dealing with unanticipated mortality in a large randomized clinical trial of topical tretinoin. Arch Dermatol. 2009 Jan; 145(1):76.
Score: 0.057
-
Dellavalle RP, Freeman SR, Williams HC. Clinical evidence epistemology. J Invest Dermatol. 2007 Nov; 127(11):2668-9.
Score: 0.051
-
Freeman SR, Drake AL, Heilig LF, Graber M, McNealy K, Schilling LM, Dellavalle RP. Statins, fibrates, and melanoma risk: a systematic review and meta-analysis. J Natl Cancer Inst. 2006 Nov 01; 98(21):1538-46.
Score: 0.049
-
Dellavalle RP, Drake A, Graber M, Heilig LF, Hester EJ, Johnson KR, McNealy K, Schilling L. Statins and fibrates for preventing melanoma. Cochrane Database Syst Rev. 2005 Oct 19; (4):CD003697.
Score: 0.046
-
Dellavalle RP, Nicholas MK, Schilling LM. Melanoma chemoprevention: a role for statins or fibrates? Am J Ther. 2003 May-Jun; 10(3):203-10.
Score: 0.038
-
Sawangjit R, Dilokthornsakul P, Lloyd-Lavery A, Lai NM, Dellavalle R, Chaiyakunapruk N. Systemic treatments for eczema: a network meta-analysis. Cochrane Database Syst Rev. 2020 09 14; 9:CD013206.
Score: 0.032
-
Karimkhani C, Reddy BY, Dellavalle RP, Sundararajan S. Novel therapies for unresectable and metastatic melanoma. BMJ. 2017 11 30; 359:j5174.
Score: 0.026
-
Thorlacius L, Ingram JR, Garg A, Villumsen B, Esmann S, Kirby JS, Gottlieb AB, Merola JF, Dellavalle R, Christensen R, Jemec GB. Protocol for the development of a core domain set for hidradenitis suppurativa trial outcomes. BMJ Open. 2017 02 20; 7(2):e014733.
Score: 0.025
-
Collier A, Johnson KR, Delamere F, Leonard T, Dellavalle RP, Williams H. The Cochrane Skin Group: promoting the best evidence. J Cutan Med Surg. 2005 Dec; 9(6):324-31.
Score: 0.012
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|